Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03206814 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System

Study acronym: CHARGE-APP
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 27, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Dec 2024 to Dec 2025v13
  2. Study sites: 2 to 8v12
  3. Primary and study completion dates: Dec 2023 to Dec 2024v11
  4. Primary completion date: Jun 2022 to Dec 2023
    • Study completion date: Dec 2022 to Dec 2023
    v10
  5. Study sites: 1 to 2v9
Show 7 earlier versionsHide 7 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2021 to May 11, 2021
    v8
  2. Primary completion date: Mar 2021 to Jun 2022
    • Start date: Mar 2021 to Jun 2021
    • Study completion date: Mar 2021 to Dec 2022
    v7
  3. Start date: Sep 2020 to Mar 2021v6
  4. Start date: Mar 2020 to Sep 2020v5
  5. Start date: Sep 2019 to Mar 2020
    • Primary and study completion dates: Dec 2020 to Mar 2021
    v4
  6. Primary completion date: Nov 2019 to Dec 2020
    • Start date: Sep 2018 to Sep 2019
    • Study completion date: May 2020 to Dec 2020
    v3
  7. Start date: Nov 2017 to Sep 2018v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The CHARGE-APP project will investigate whether an innovative management strategy of hypertension based on the combination of usual care visits and ESH CARE App compared to standard care, is associated with differences in outcome, including control rate of office, home and ambulatory BP, cardiovascular and renal intermediate end points at one year, and changes in a number of blood pressure-related variables throughout the study.
Trial Details
NCT Number NCT03206814
Lead Sponsor Istituto Auxologico Italiano
Conditions
(from sponsor)		 Hypertension,Essential, Hypertension, Uncontrolled
Related terms Essential Hypertension, Hypertension
Enrollment 480 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov